+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer



Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer



Gastroenterology 121(3): 640-645



Background and Aims: Islet amyloid polypeptide (IAPP) levels are elevated in pancreatic cancer and may be a useful marker of pancreatic cancer-associated diabetes. The aim of this study was to compare the sensitivity and specificity for pancreatic cancer of IAPP with that of CA19-9, examine clinical characteristics of diabetes in pancreatic cancer, and define the relationship of IAPP to diabetes of pancreatic cancer. Methods: Fasting serum glucose, IAPP, and CA 19-9 were measured in 130 subjects with pancreatic cancer, 250 subjects with other pancreatic and peripancreatic diseases, and 116 controls. In pancreatic cancer patients, we noted tumor stage and the presence and duration of diabetes. Results: IAPP was markedly elevated in pancreatic cancer, especially in patients with diabetes. However, the sensitivity of IAPP for pancreatic cancer was less than that of CA 19-9 (40% vs. 75%; P<0.001). Diabetes was present in 46% of pancreatic cancers and 55% of resectable tumors. In pancreatic cancer with diabetes, the sensitivity of IAPP was only 50%. In resectable cancer it was 27%. Conclusions: IAPP is elevated in pancreatic cancer but is not sensitive enough to replace or complement existing tests. Diabetes occurs early and frequently in pancreatic cancer. Development of a sensitive and specific marker for pancreatic-associated diabetes might lead to diagnosis of resectable pancreatic cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010889076

Download citation: RISBibTeXText

PMID: 11522748

DOI: 10.1053/gast.2001.27210


Related references

Presence of islet amyloid polypeptide in rat islet B and D cells determines parallelism and dissociation between rat pancreatic islet amyloid polypeptide and insulin content. Biochemical and Biophysical Research Communications 182(2): 886-893, 1992

Plasma islet amyloid polypeptide is not an effective tumor marker for pancreatic cancer even when protease inhibitors and rapid freezing of specimens are utilized. Clinical Chemistry 47(11): 2071-2073, 2001

Regulation of expression of the islet amyloid polypeptide gene, a possible early marker of pancreatic carcinoma. Gastroenterology 118(4 Suppl 2 Part 1): AGA A642, 2000

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proceedings of the National Academy of Sciences of the United States of America, 93(8): 3492-3496, 1996

Formation of islet amyloid in pancreatic islets from transgenic mice expressing human islet amyloid polypeptide. Clinical Science (London) 87(1): 39P, 1994

Two novel immortal pancreatic beta-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid. Diabetes 48(10): 1962-1970, 1999

Is islet amyloid polypeptide the cause of diabetes in pancreatic cancer?. Digestion 52(2): 112, 1992

Could islet amyloid polypeptide contribute to the cachexia of pancreatic cancer?. Gastroenterology 104(4 SUPPL ): A294, 1993

Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. New England Journal of Medicine 330(5): 313-318, 1994

The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors. Biochemistry 49(5): 872-881, 2010

On the role of islet amyloid polypeptide in glucose intolerance and anorexia of pancreatic cancer. Pancreatology 1(3): 267-274, 2002

Unaltered pancreatic islet blood perfusion in islet amyloid polypeptide-deficient mice. European Journal of Endocrinology 146(1): 107-112, 2002

Unaltered pancreatic islet blood perfusion in islet amyloid polypeptide-deficient mice. European Journal of Endocrinology 146(1): 107-112, 2001

Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: Lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 36(12): 1258-1265, 1993